Epidemic Typhus Pathogenesis

流行性斑疹伤寒发病机制

基本信息

  • 批准号:
    7860353
  • 负责人:
  • 金额:
    $ 16.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-05 至 2011-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Epidemic typhus, also known as Gaol fever, Jail fever, or Famine fever, is caused by the Gram-negative bacterium Rickettsia prowazekii. This louse-borne disease has been responsible for devastating widespread epidemics throughout history, especially during and after the wars, famine, and poor socio-economic conditions, and is the only known rickettsiosis that can recur after a long period of latency (Brill-Zinsser disease). R. prowazekii is classified as a CDC/NIAID Category B biological warfare pathogen, the entire genome for which was the first to be sequenced among all known Rickettsia species. Although tremendous strides have recently been made in the genetic manipulation of R. prowazekii, the knowledge of molecular aspects of interactions with the vascular endothelium, the preferred cell type infected during human infections, still remains in its infancy. Endothelial cells, key immunoreactive cells involved in host defense and inflammation, are also intimately involved in the manifestations of rickettsial infections. On the basis of interactions of host endothelial cells with R. prowazekii and R. typhi (the etiologic agent of endemic typhus), we have identified activation of nuclear factor kappa B (NF-?B) and stress-activated p38 protein kinase as critically important regulatory signaling mechanisms that contribute to host cell activation and responses to infection. Specific Aim 1 of this exploratory grant application is designed to define the intensity and kinetics of the activation of NF-?B and MAP kinase signaling pathways after R. prowazekii infection of vascular endothelial cells in vitro and test the hypothesis that potential differences in intracellular signaling mechanisms determine the intensity of host cell activation in response to virulent Breinl versus attenuated Madrid E versus virulent revertant Evir strains of R. prowazekii. Aim 2 will focus on establishing and characterizing a mouse model of R. prowazekii infection that closely mimics the major pathological features, i.e. disseminated endothelial infection and vascular inflammation, of epidemic typhus disease in humans. Taken together, these studies will address critical gaps in our current understanding of in vitro and in vivo interactions between vascular endothelium and R. prowazekii and mechanisms underlying 'endothelial activation' during typhus rickettsioses. The long-term objective of this project is to establish the foundation for comprehensive understanding of epidemic typhus pathogenesis by identifying specialized vascular cell signaling pathways activated in vitro and subsequent detailed analysis of their involvement in determination of innate and adaptive immune responses with an aim to develop unique chemotherapeutic strategies focused at targeted intervention. In addition, detailed characterization of a small animal model of infection akin to disease in humans will allow us to define unique features of virulence factors and pathogenesis of epidemic typhus, to expand our understanding of in vivo immune responses, and to test the efficacy of novel antibiotics and vaccine candidates. PUBLIC HEALTH RELEVANCE: Typhus epidemics due to louse-borne Rickettsia prowazekii have caused more deaths than all the wars combined and recent epidemiological evidence documents the reemergence of epidemic typhus in different geographic locations of the world. Since vascular dysfunction and damage are the major pathologic sequelae responsible for complications of human rickettsial diseases, obtaining a definition of signaling interactions between host endothelial cells and R. prowazekii strains of varying virulence and detailed characterization of a mouse model of disseminated infection of the vasculature represent first major steps in advancing our understanding of pathogenesis of epidemic typhus, which will ultimately lead to the development of novel therapeutic and immunologic strategies to combat this debilitating rickettsial disease.
描述(由申请人提供):流行性斑疹伤寒,也称为监狱热、监狱热或饥荒热,由革兰氏阴性细菌普氏立克次体引起。这种虱传疾病在整个历史上,特别是在战争、饥荒和社会经济条件差期间和之后,造成了毁灭性的广泛流行,并且是唯一已知的在长时间潜伏后可以复发的立克次体病(布-津二氏病)。R.普氏立克次氏体被分类为CDC/NIAID B类生物战病原体,其整个基因组是所有已知立克次体物种中第一个被测序的。虽然最近在R. Prowazekii,与血管内皮(在人类感染期间感染的优选细胞类型)相互作用的分子方面的知识仍然处于起步阶段。内皮细胞,参与宿主防御和炎症的关键免疫反应细胞,也密切参与立克次体感染的表现。根据宿主内皮细胞与R. prowazekii和R.伤寒(地方性斑疹伤寒的病原体),我们已经确定激活核因子κ B(NF-?B)和应激活化的p38蛋白激酶作为促进宿主细胞活化和对感染的应答的至关重要的调节信号传导机制。具体目标1的探索性赠款申请的目的是确定强度和动力学的NF-?B和MAP激酶信号通路在R. prowazekii体外感染血管内皮细胞,并检验以下假设:细胞内信号传导机制的潜在差异决定了宿主细胞对强毒Breinl、减毒马德里E和强毒回复突变体Evir菌株的应答强度。prowazekii。目的二是建立和鉴定小鼠红细胞白血病模型。这种感染与人类流行性斑疹伤寒病的主要病理特征,即播散性内皮感染和血管炎症非常相似。总之,这些研究将解决我们目前对血管内皮和R之间的体外和体内相互作用的理解中的关键差距。prowazekii和斑疹伤寒立克次体病过程中“内皮激活”的机制。本项目的长期目标是通过识别体外激活的专门的血管细胞信号通路,并随后详细分析其参与确定先天性和适应性免疫应答,从而为全面了解流行性斑疹伤寒发病机制奠定基础,旨在开发独特的化疗策略,重点是靶向干预。此外,类似于人类疾病的小动物感染模型的详细表征将使我们能够定义流行性斑疹伤寒毒力因子和发病机制的独特特征,扩大我们对体内免疫反应的理解,并测试新型抗生素和候选疫苗的功效。公共卫生关系:由虱传播的普氏立克次体引起的斑疹伤寒流行病造成的死亡人数比所有战争的总和还要多,最近的流行病学证据证明,流行性斑疹伤寒在世界不同的地理位置重新出现。由于血管功能障碍和损伤是导致人类立克次体病并发症的主要病理后遗症,因此获得宿主内皮细胞与立克次体之间信号相互作用的定义。不同毒力的prowazekii菌株和脉管系统播散性感染的小鼠模型的详细表征代表了推进我们对流行性斑疹伤寒发病机制的理解的第一个主要步骤,这将最终导致开发新的治疗和免疫策略来对抗这种使人衰弱的立克次体病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sanjeev K. Sahni其他文献

Sanjeev K. Sahni的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sanjeev K. Sahni', 18)}}的其他基金

Role of mTOR signaling in endothelial responses to Rickettsia rickettsii infection.
mTOR 信号传导在内皮细胞对立克次体感染反应中的作用。
  • 批准号:
    9979543
  • 财政年份:
    2020
  • 资助金额:
    $ 16.12万
  • 项目类别:
Riboregulation in Pathogenic Rickettsiae
致病性立克次体的核糖调节
  • 批准号:
    9089911
  • 财政年份:
    2015
  • 资助金额:
    $ 16.12万
  • 项目类别:
Host Cell JAK-STAT Activation and Pathogenesis of Spotted Fever Rickettsioses
宿主细胞 JAK-STAT 激活和斑点热立克次体病的发病机制
  • 批准号:
    8524206
  • 财政年份:
    2012
  • 资助金额:
    $ 16.12万
  • 项目类别:
Epidemic Typhus Pathogenesis
流行性斑疹伤寒发病机制
  • 批准号:
    8334983
  • 财政年份:
    2009
  • 资助金额:
    $ 16.12万
  • 项目类别:
Epidemic Typhus Pathogenesis
流行性斑疹伤寒发病机制
  • 批准号:
    7738755
  • 财政年份:
    2009
  • 资助金额:
    $ 16.12万
  • 项目类别:
Modulation of Host Cell Apoptosis By Pathogenic Rickettsiae
致病性立克次体对宿主细胞凋亡的调节
  • 批准号:
    7211768
  • 财政年份:
    2007
  • 资助金额:
    $ 16.12万
  • 项目类别:
Modulation of Host Cell Apoptosis By Pathogenic Rickettsiae
致病性立克次体对宿主细胞凋亡的调节
  • 批准号:
    7465458
  • 财政年份:
    2007
  • 资助金额:
    $ 16.12万
  • 项目类别:
Regulatory Oxygenases in Vasculopathic Rickettsioses
血管病性立克次体病中的调节性氧化酶
  • 批准号:
    7806372
  • 财政年份:
    2006
  • 资助金额:
    $ 16.12万
  • 项目类别:
Regulatory Oxygenases in Vasculopathic Rickettsioses
血管病性立克次体病中的调节性氧化酶
  • 批准号:
    8335027
  • 财政年份:
    2006
  • 资助金额:
    $ 16.12万
  • 项目类别:
Regulatory Oxygenases in Vasculopathic Rickettsioses
血管病性立克次体病中的调节性氧化酶
  • 批准号:
    7614391
  • 财政年份:
    2006
  • 资助金额:
    $ 16.12万
  • 项目类别:

相似海外基金

AEROSOLS
气雾剂
  • 批准号:
    10101317
  • 财政年份:
    2024
  • 资助金额:
    $ 16.12万
  • 项目类别:
    EU-Funded
AEROSOLS - AIR QUALITY AND HEALTH IMPACT OF PRIMARY SEMI-VOLATILE AND SECONDARY PARTICLES AND THEIR ABATEMENT
气溶胶 - 一次半挥发性颗粒和二次颗粒对空气质量和健康的影响及其消除
  • 批准号:
    10092043
  • 财政年份:
    2024
  • 资助金额:
    $ 16.12万
  • 项目类别:
    EU-Funded
Molecular-level Understanding Of Atmospheric Aerosols (MUOAA 2024); Corsica, France; April 1-5, 2024
对大气气溶胶的分子水平理解(MUOAA 2024);
  • 批准号:
    2332007
  • 财政年份:
    2024
  • 资助金额:
    $ 16.12万
  • 项目类别:
    Standard Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
  • 批准号:
    NE/Y000021/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.12万
  • 项目类别:
    Research Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
  • 批准号:
    NE/Y000358/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.12万
  • 项目类别:
    Research Grant
Southern Ocean aerosols: sources, sinks and impact on cloud properties
南大洋气溶胶:来源、汇以及对云特性的影响
  • 批准号:
    DP240100389
  • 财政年份:
    2024
  • 资助金额:
    $ 16.12万
  • 项目类别:
    Discovery Projects
INvestigating Home water and Aerosols' Links to opportunistic pathogen Exposure (INHALE): do consumer decisions impact pathogen exposure and virulence?
调查家庭用水和气溶胶与机会性病原体暴露(吸入)的联系:消费者的决定是否会影响病原体暴露和毒力?
  • 批准号:
    2326096
  • 财政年份:
    2023
  • 资助金额:
    $ 16.12万
  • 项目类别:
    Standard Grant
An AI-driven clinical washbasin unit that automatically disinfects pathogens, reduces aerosols and decreases healthcare-acquired infections by 70%
%20人工智能驱动%20临床%20洗脸盆%20单位%20%20自动%20消毒%20病原体,%20减少%20气溶胶%20和%20减少%20医疗保健获得性%20感染%20by%2070%
  • 批准号:
    83001507
  • 财政年份:
    2023
  • 资助金额:
    $ 16.12万
  • 项目类别:
    Innovation Loans
Cloudbusting with JWST: characterising aerosols, aurorae and chemistry in substellar atmospheresto the water cloud regime
使用 JWST 进行云消除:描述水云状态下恒星大气中的气溶胶、极光和化学成分
  • 批准号:
    ST/X001091/1
  • 财政年份:
    2023
  • 资助金额:
    $ 16.12万
  • 项目类别:
    Research Grant
Bioactivated Aerosols for Combustion Product Capture
用于燃烧产物捕获的生物活性气溶胶
  • 批准号:
    10080253
  • 财政年份:
    2023
  • 资助金额:
    $ 16.12万
  • 项目类别:
    Small Business Research Initiative
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了